Navigation Links
Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
Date:12/28/2007

Pafuramidine on Clinical Hold

Loramyc(R) Completes Patient Enrollment Ahead of Schedule

Zensana(TM) Reformulation Complete, Resubmission on Target

WOODCLIFF LAKE, N.J., Dec. 28 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today provided an update on the development status of its three, in-licensed, proprietary pipeline products: pafuramidine, Loramyc(R) (miconazole Lauriad(R)), and Zensana(TM) (ondansetron). These three products represent the current product pipeline of Strativa Pharmaceuticals, Par's proprietary products division.

Pafuramidine maleate for pneumocystis pneumonia (PCP) in AIDS patients:

In June 2007, Par Pharmaceutical, Inc. entered into an exclusive licensing agreement under which Par received commercialization rights in the U.S. to Immtech Pharmaceuticals' Phase III lead oral drug candidate, pafuramidine maleate, for the treatment of pneumocystis pneumonia (PCP) in AIDS patients.

Earlier this week, Immtech Pharmaceuticals, Inc. announced that after discussion with the U.S. Food and Drug Administration (FDA), the pafuramidine program has been placed on clinical hold. In preliminary findings from an in- progress safety study at a South African site, abnormal laboratory values were found in several volunteers following treatment with pafuramidine.

In this South African safety study volunteers were dosed with pafuramidine 100 mg or placebo twice daily for 14 days. The subjects are undergoing close monitoring for any changes in the status of their liver function. No subject has required any treatment or hospitalization for the abnormalities to date. This evaluation will continue until patients stabilize or return to baseline
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Introducing Strativa Pharmaceuticals
2. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
3. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
4. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
5. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
6. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
7. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
8. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
9. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
10. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
11. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Diego, California (PRWEB) July 23, 2014 With ... second in HD resolution for more than 15 minutes, Fastec ... to the world of high speed imaging. “Finally, a high ... other camera we use in our everyday lives.” proclaims Matt ... at Fastec has always been to demystify and simplify the ...
(Date:7/23/2014)... MA (PRWEB) July 23, 2014 ... medicine transplant therapies are biological, but not magical. ... may seem to treat them as if they ... well as unsanctioned studies that constitute “stem cell ... as an approach to developing new regenerative medicine ...
(Date:7/22/2014)... July 22, 2014 The Board of Directors of ... has declared a quarterly dividend of 54.5 cents per common ... on September 9, 2014. The indicated annual dividend rate is ... BD is a leading medical technology company that partners with ... pressing and evolving health needs. Our innovative solutions are focused ...
(Date:7/22/2014)... of rod-shaped metal nanoparticles in water with ultrasound and ... bits. Why? No one yet knows exactly. But researchers ... have clocked their speedand it,s fast. At up to ... faster than any nanoscale object submerged in liquid ever ... opened up the possibility that they could be used ...
Breaking Biology Technology:Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 4The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 5NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2
... All Conditions to the Tender Offer Have Been Satisfied, ... and,Investments Ltd. (TASE: CII) announced today that all of ... to purchase,up to 2,338,686 ordinary shares of Fundtech Ltd. ... to the seller in cash, less any required,withholding taxes ...
... and employees in Massachusetts, encompassing over 250,000 square feet for ... ... CANTON, Mass., April 3, 2008 Joined by local officials,and Organogenesis, ... company, which was once,planning to move its operations outside of the ...
... DNDN ) today announced that it has entered into ... million shares of its,common stock and warrants to purchase ... gross proceeds of approximately $47 million, before,deducting placement agent ... The investor has agreed to purchase the,shares of common ...
Cached Biology Technology:Clal Industries Commences Additional Offer Period for Fundtech Tender Offer 2Clal Industries Commences Additional Offer Period for Fundtech Tender Offer 3Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis' New Headquarters 2Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis' New Headquarters 3Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis' New Headquarters 4Dendreon Announces $47 Million Registered Direct Offering 2Dendreon Announces $47 Million Registered Direct Offering 3
(Date:7/23/2014)... membrane degradation and blood-brain barrier damage appear ... brain functioning. Matrix metalloproteinase-9 is able to ... membrane around cerebral blood vessels and to ... Hou and colleagues from the First Affiliated ... University, China induced cerebral infarction in stroke-prone ...
(Date:7/23/2014)... German . ... of Molecular Cell Biology and Genetics in Dresden ... images of cardiac dynamics in zebrafish. The novel ... (SPIM) and clever image processing to reconstruct multi-view ... have developed a method of generating high-resolution static ...
(Date:7/22/2014)... professor with an expertise in big data and bioinformatics ... more than $600,000 to develop an interactive database of ... associate professor, will lead the project with professor Chris ... Engineering department. Scientists are compiling and studying data related ... involved in fruit fly development are commonly found in ...
Breaking Biology News(10 mins):Unbreak my heart 2UT Arlington big data team wins $600,000 NSF grant to build gene expression database 2
... Society for Cell Biology is inviting the general public to ... Evening of Art & Science" at the Moscone Center in ... the public who sign up for free online at ... addresses by Stephen Chu, Nobel prize laureate and U.S. Secretary ...
... of Missouri researcher Mark Flinn, professor of anthropology, has ... Advancement of Science fellow for his "theoretical contributions in ... for pioneering field research on stress response, family environment, ... Election as a fellow of the ...
... the focus of an upcoming workshop at the Institute ... 29 November-1 December, 2012), according to the Malaysian Department ... Society. The gatheringthe first of its kind ... 60 participants, including stakeholders from the logging industry, oil ...
Cached Biology News:Public invited to 'An Evening of Science & Art' at ASCB Annual Meeting 2Cultural anthropologist Mark Flinn named 2013 AAAS Fellow 2Conservationists to create blueprint for saving Malaysia's elephants 2
Competitors to lower non-specific signal...
ExonBio Service provides one-stop recobinant protein shopping from cloning, expression and purification. Price including gene cloning....
Anti-ZFP200 Family: Zinc Finger Peptide Sequence: CGKSFNHKTNLNKHER...
1000X solution used for inducing CopyControl™ based vectors to high copy numbers...
Biology Products: